41 related articles for article (PubMed ID: 22563819)
1. Zoledronic acid suppresses mineralization through direct cytotoxicity and osteoblast differentiation inhibition.
Patntirapong S; Singhatanadgit W; Chanruangvanit C; Lavanrattanakul K; Satravaha Y
J Oral Pathol Med; 2012 Oct; 41(9):713-20. PubMed ID: 22563819
[TBL] [Abstract][Full Text] [Related]
2. Increased numbers of nonattached osteoclasts after long-term zoledronic acid therapy in mice.
Kuroshima S; Go VA; Yamashita J
Endocrinology; 2012 Jan; 153(1):17-28. PubMed ID: 22109892
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of fatty acid biosynthesis prevents adipocyte lipotoxicity on human osteoblasts in vitro.
Elbaz A; Wu X; Rivas D; Gimble JM; Duque G
J Cell Mol Med; 2010 Apr; 14(4):982-91. PubMed ID: 19382912
[TBL] [Abstract][Full Text] [Related]
4. Zoledronic acid inhibits human osteoblast activities.
Basso FG; Silveira Turrioni AP; Hebling J; de Souza Costa CA
Gerontology; 2013; 59(6):534-41. PubMed ID: 23867757
[TBL] [Abstract][Full Text] [Related]
5. Dose-dependent inhibitory effects of zoledronic acid on osteoblast viability and function in vitro.
Huang X; Huang S; Guo F; Xu F; Cheng P; Ye Y; Dong Y; Xiang W; Chen A
Mol Med Rep; 2016 Jan; 13(1):613-22. PubMed ID: 26648136
[TBL] [Abstract][Full Text] [Related]
6. Effects of alendronate and pamidronate on apoptosis and cell proliferation in cultured primary human gingival fibroblasts.
Soydan SS; Araz K; Senel FV; Yurtcu E; Helvacioglu F; Dagdeviren A; Tekindal MA; Sahin F
Hum Exp Toxicol; 2015 Nov; 34(11):1073-82. PubMed ID: 25636638
[TBL] [Abstract][Full Text] [Related]
7. Polysacharide of Agaricus blazei gel mitigates bone necrosis in model of the jaws related to bisphosphonate via Wnt signaling.
Costa de Sousa V; Nunes Sousa FR; Felipe Vasconcelos R; Angelino Barreto G; Martins CS; Romero Dias N; Costa S; Chaves Bernardino MJ; de Almeida Silva G; Linhares N; Gondim D; Marques M; Chaves H; Alves K; Leitão R; Brito GAC; Nobre Pinho Ribeiro ME; Goes P
Sci Rep; 2024 Apr; 14(1):8215. PubMed ID: 38589479
[TBL] [Abstract][Full Text] [Related]
8. Biomimetic Collagen Membranes as Drug Carriers of Geranylgeraniol to Counteract the Effect of Zoledronate.
Manzano-Moreno FJ; de Luna-Bertos E; Toledano-Osorio M; Urbano-Arroyo P; Ruiz C; Toledano M; Osorio R
Biomimetics (Basel); 2023 Dec; 9(1):. PubMed ID: 38248578
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of Bone Regenerative Capacity in Rabbit Femoral Defect Using Thermally Disinfected Bone Human Femoral Head Combined with Platelet-Rich Plasma, Recombinant Human Bone Morphogenetic Protein 2, and Zoledronic Acid.
Saginova D; Tashmetov E; Kamyshanskiy Y; Tuleubayev B; Rimashevskiy D
Biomedicines; 2023 Jun; 11(6):. PubMed ID: 37371824
[TBL] [Abstract][Full Text] [Related]
10. Bevacizumab and sunitinib mediate osteogenic and pro-inflammatory molecular changes in primary human alveolar osteoblasts in vitro.
Hofmann E; Eggers B; Heim N; Kramer FJ; Nokhbehsaim M; Götz W
Odontology; 2022 Oct; 110(4):634-647. PubMed ID: 35171372
[TBL] [Abstract][Full Text] [Related]
11. Geranylgeraniol prevents zoledronic acid-mediated reduction of viable mesenchymal stem cells via induction of Rho-dependent YAP activation.
Singhatanadgit W; Hankamolsiri W; Janvikul W
R Soc Open Sci; 2021 Jun; 8(6):202066. PubMed ID: 34113452
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory Effects of Alendronate on Adhesion and Viability of Preosteoblast Cells on Titanium Discs.
Lilakhunakon C; Suwanpateeb J; Patntirapong S
Eur J Dent; 2021 Jul; 15(3):502-508. PubMed ID: 34100275
[TBL] [Abstract][Full Text] [Related]
13. Standardized
Wiziack Zago PM; Oliveira Sousa IM; Servat-Medina L; Jorge MP; Lima Neto LG; Hass V; Li X; Tasca Gois Ruiz AL; Saxena D; Foglio MA
Clin Cosmet Investig Dent; 2020; 12():327-333. PubMed ID: 32848479
[TBL] [Abstract][Full Text] [Related]
14. Synergistic effect of graphene oxide and zoledronic acid for osteoporosis and cancer treatment.
Boran G; Tavakoli S; Dierking I; Kamali AR; Ege D
Sci Rep; 2020 May; 10(1):7827. PubMed ID: 32385391
[TBL] [Abstract][Full Text] [Related]
15.
Liu H; Gu R; Li W; Zhou W; Cong Z; Xue J; Liu Y; Wei Q; Zhou Y
Ther Adv Chronic Dis; 2019; 10():2040622319860653. PubMed ID: 31321013
[TBL] [Abstract][Full Text] [Related]
16. Nitrogen Containing Bisphosphonates Impair the Release of Bone Homeostasis Mediators and Matrix Production by Human Primary Pre-Osteoblasts.
Giannasi C; Niada S; Farronato D; Lombardi G; Manfredi B; Farronato G; Brini AT
Int J Med Sci; 2019; 16(1):23-32. PubMed ID: 30662325
[TBL] [Abstract][Full Text] [Related]
17. Cytokine Mixtures Mimicking Secretomes From Mesenchymal Stem Cells Improve Medication-Related Osteonecrosis of the Jaw in a Rat Model.
Ogata K; Matsumura M; Moriyama M; Katagiri W; Hibi H; Nakamura S
JBMR Plus; 2018 Mar; 2(2):69-80. PubMed ID: 30283893
[TBL] [Abstract][Full Text] [Related]
18. Prior administration of vitamin K2 improves the therapeutic effects of zoledronic acid in ovariectomized rats by antagonizing zoledronic acid-induced inhibition of osteoblasts proliferation and mineralization.
Zhao B; Zhao W; Wang Y; Zhao Z; Zhao C; Wang S; Gao C
PLoS One; 2018; 13(8):e0202269. PubMed ID: 30125322
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
